| Synonyms |
Canertinib;CI-1033;PD-183805;N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;N-[4-(3-chloro-4-fluoro-anilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]acrylamide;CI-1033(Canertinib);Canertinib base;Canetinib;Canertinib (CI-1033);N-[4-(3-chloro-4-fluoroanilino)-7-(3-Morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-en;2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazoliny...;2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-;Canertinib (CI-1033,CI 1033, PD-183805, PD-0183805);N-(4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide;UNII-C78W1K5ASF;N-[4-(3-Chloro-4-fluoroanilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]acrylamide;N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide;C78W1K5ASF;CI1033;PD183805;N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide;N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)prop;HMS3244M17;CANETINIB;SCHEMBL54837;NSC780019;FT-0654215;NCGC00182713-01;HMS3244M18;Canertinib [INN:BAN];EX-A078;Caneritinib; CI-1033;A25038;OMZCMEYTWSXEPZ-UHFFFAOYSA-N;GTPL5675;DTXSID8048943;Tox21_113361;BCP9000481;Z166624030;267243-28-7 (free base);Q5032274;MLS004774146;cid_156414;BDBM4779;BCP01790;s1019;N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide;CANERTINIB [MI];CHEBI:61399;DB05424;DTXCID1028869;NSC801011;NSC-780019;N-(4-(3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-MORPHOLIN-4-YL)PROPOXY)QUINAZOLIN-6-YL)PROP-2-ENAMIDE;CI-1033 (Canertinib);AS-56189;HY-10367;CCG-269588;SN-26606;267243-28-7;Canertinib free base;Canertinib [INN];BCPP000301;BCP9000482;CS-0121;SB16594;N-[4-(3-chloro-4-fluoro-anilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]prop-2-enamide;NCGC00182713-02;EN300-6493001;CAS-267243-28-7;PD 183805 dihydrochloride;HMS3244N17;NSC-801011;N-(4-(3-chloro-4-fluorophenylamino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide;NCGC00182713-18;SMR003500789;NS00071801;CANERTINIB [WHO-DD];BCP9000525;CHEMBL31965;AKOS005145818;PD0183805;2-PROPENAMIDE, N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-(4-MORPHOLINYL)PROPOXY)-6-QUINAZOLINYL)-;N-[4-(3-chloro-4-fluoro-phenyl-amino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide |
11-anilino-7,8,9,10-tetrahydrobenzimidazo[1,2-b]isoquinoline-6-carbonitrile
COA
